Baclofen-induced antinociception and nicotinic receptor mechanism(s)

Pharmacology and Toxicology

Volumn 85, Issue 5, 1999, Pages 247-251

  Sabetkasai, M ^a   Ahang, S ^a   Shafaghi, B ^a   Zarrindast, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; BACLOFEN; HEXAMETHONIUM; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANIMALIA;

EID: 0032754495     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb02017.x     Document Type: Article

References (52)

1. Aceto, M. D., R. S. Bagley, W. L. Dewey, T. C. Fu & B. R. Martin: The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology 1986, 25, 1031-1036.
2. Balfour, D. J. K.: The effects of nicotine on brain neurotransmitters systems. Pharmacol. Therap. 1982, 16, 269-282.
3. Bartolini, A., R. Malmberg, R. Bartolini & A. Giotti: Effect of antimigraine drugs on nonopioid analgesia. Adv. Neurol. 1982, 33, 89-97.
4. B receptor subtypes. Trends Neurosci. 1988, 11, 112-116.
5. Bowery, N. G.: Baclofen 10 years on. Trends Pharmacol. Sci. 1982, 3, 400-403.
6. Bowery, N. G., A. Doble, D. R. Hill, A. L. Hudson, J. S. Shaw, M. J. Turnbull & R. Warrington: Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. Eur. J. Pharmacol. 1981, 71, 53-70.
7. Bowery, N. G., D. R. Hill, A. L. Hudson, A. Doble, D. N. Middlemiss, J. Shaw & M. J. Turnbull: (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel receptor. Nature 1980, 283, 92-94.
8. Clarke, P. B. S.: Dopaminergic mechanism in the locomotor stimulant effect of nicotine. Biochem. Pharmacol. 1990, 40, 1427-1432.
9. Clarke, P. B. S. & A. Pert: Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 1985, 348, 355-358.
10. Cutting, D. A. & C. C. Jordan: Alternative aproaches to analgesia: baclofen as a model compound. Brit. J. Pharmacol. 1975, 54, 171-179.
11. DeFeudis, F. V.: GABA receptors in the vertebrate nervous system. Progr. Neurobiol. 1977, 9, 123-145.
12. Drew, C. A., G. A. R. Johnston & R. P. Weatherby: Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes. Neurosci. Lett. 1984, 52, 317-321.
13. Fromm, G. H., C. P. Terrence & A. S. Chattha: Baclofen in the treatment of trigeminal neuralgia: Double blind study and long-term follow up. Ann. Neurol. 1984, 15, 240-244.
14. Gianutsos, G. & K. E. Moore: Tolerance to the effects of baclofen and γ-butyrolactone on locomotor activity and dopaminergic neurons in the mouse. J. Pharmacol. Exp. Therap. 1978, 207, 859-869.
15. Giorguieff, M. F., M. L. Kemel, D. Wandscheer & J. Glowinski: Regulation of dopamine release by presynaptic receptors in rat striatal slices: Effect of nicotine in a low concentration. Life Sci. 1979, 25, 1257-1262.
16. 14C-dopamine in rat brain striatum and hypothalamus slices. Neuropharmacology 1974, 13, 1025-1032.
17. Grenhoff, J., G. Aston-Jones & T. H. Svenson: Nicotine effects on the firing pattern of mid-brain dopamine neurons. Acta physiol. scand. 1986, 128, 351-358.
18. B sites in rat brain. Nature 1981, 290, 149-152.
19. Hill, R. C., R. Maurer, H. H. Buescher & D. Roemer: Analgesic properties of the GABA-mimetic THIP. Eur. J. Pharmacol. 1981, 69, 221-224.
20. Imperato, A., A. Mulus & G. Di Chiara: Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 1986, 132, 337-338.
21. Iwamoto, E. T.: Antinociception after nicotine administration into the mesolimbic tegmentum of rats: evidence for muscarinic actions. J. Pharmacol. Exp. Therap. 1989, 251, 412-421.
22. Jiang, Q., H. I. Mosberg & F. Poreca: Selective modulation of morphine antinociception, but not development of tolerance by receptor. Eur. J. Pharmacol. 1990, 186, 137-141.
23. Johnston, G. A. R.: Neuropharmacology of amino acid inhibitory transmitters. Ann. Rev. Pharmacol. Toxicol. 1978, 18, 269-289.
24. C receptors: relatively simple transmitter-gated ion channels? Trends Pharmacol. Sci. 1996, 17, 319-323.
25. Kendall, D. A., M. Browner & S. J. Enna: Comparison of the antinociceptive effect of γ-aminobutyric acid (GABA) agonist: evidence for a cholinergic involvement. J. Pharmacol. Exp. Therap. 1982, 220, 482-487.
26. Levy, R. A. & H. K. Proudfit: The analgesic action of baclofen (b(4-chlorophenyl)-y-aminobutyric acid). J. Pharmacol. Exp. Therap. 1977, 202, 437-445.
27. Mansmer, R.: Relation between some central effects of nicotine and its brain levels in the mouse. Ann. Med. Exp. Biol. Fenn. 1972, 50, 205-212.
28. Martin, B. R., H. L. Tripathi, M. D. Aceto & E. L. May: Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions. J. Pharmacol. Exp. Therap. 1983, 226, 157-163.
29. Mattila, M. J., L. Ahtee & L. Saarnivaara: The analgesic and sedative effects of nicotine in white mice, rabbit and golden hamsters. Ann. Med. Exp. Biol. Fenn. 1968, 46, 78-84.
30. Mereu, G., K. W. P. Yoonm, V. Boi, G. L. Gessa, L. Naes & T. C. Westfall: Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur. J. Pharmacol. 1987, 141, 395-399.
31. Molinero, M. T. & J. Del Rio: Subtance P, nicotinic acetylcholine receptors and antinociception in the rat. Neuropharmacology 1987, 26, 1715-1720.
32. Olpe, H. R., W. P. Koella, P. Wolf & H. L. Haas: The action of baclofen on neurones of the substantia nigra and of the ventral tegmental area. Brain Res. 1977, 134, 577-583.
33. Olpe, H. R., H. Demieville, V. Baltzer, W. L. Beneze, W. R. Koella, P. Wolf & H. L. Haas: The biological activity of d-and l-baclofen (Lioresal). Eur. J. Pharmacol. 1978, 52, 133-136.
34. Olpe, H. R., G. Karlsson, M. F. Tozza, F. Brugger, M. Steinmann, H. Vanriezen, G. Sagg, R. G. Hall, W. Frolestl & H. Bittiger: CGP 35348 a centrally active blocker of GABA-B receptor. Eur. J. Pharmacol. 1990, 187, 27-38.
35. Phan, D. V., M. Doda, A. Bile & L. Gyorgy: Antinociceptive activity of nicotine. Acad Sci. Hung. 1973, 1, 85-93.
36. Pinto de, S., M. Polikar & G. Debono: Results of international clinical trials with Lioresal. Postgrad. Med. J. 1972, 48 (Suppl. 5), 18-23.
37. Proudfit, H. K. & R. A. Levy: Delimitation of neuronal sibstrates necessary for the analgesic action of baclofen and morphine. Eur. J. Pharmacol. 1978, 47, 159-166.
38. Sabetkasai, M. & M. R. Zarrindast: Antinociception: interaction between adenosine and GABA systems. Arch Int. Pharmacodyn. 1993, 322, 14-22.
39. Sabetkasai, M., R. Doost-Mohammady & M. R. Zarrindast: Opposite influences of different adrenoceptors on baclofen induced antinociception in mice. Pharmacology & Toxicology 1997, 80, 6-10.
40. B mechanism involvement. Psychopharmacology 1999, 142, 426-431.
41. Sahley, T. L. & G. G. Berntson: Antinociceptive effects of central and systemic administration of nicotine in the rat. Psychopharmacology 1979, 65, 279-283.
42. Sawynok, J.: GABAergic mechanisms of analgesia: An update. Pharmacol. Biochem. Behav. 1987, 26, 463-474.
43. Sawynok, J.: Theophylline-induced potentiation of the antinociceptive action of baclofen. Brit. J. Pharmacol. 1983, 78, 353-357.
44. Sawynok, J. & F. S. LaBella: On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology 1982, 21, 397-403.
45. Sivam, S. P. & I. K. Ho: GABAergic drugs, morphine and morphine tolerance: a study in relation to nociception and gastrointestinal transit in mice. Neuropharmacology 1983, 22, 767-774.
46. Tamayo, L., J. Reid & E. Contreras: Influences of adrenergic and cholinergic mechanism in baclofen induced analgesia. Gen. Pharmacol. 1988, 19, 87-89.
47. Tripathi, H. L., B. R. Martin & M. D. Aceto: Nicotine induced antinociception in rats and mice. Correlation with nicotine brain levels. J. Pharmacol. Exp. Therap. 1982, 221, 91-96.
48. Young, R. R. & P. J. Delwaide: Drug therapy: Spasticity. New Engl. J. Med. 1981, 304, 96-99.
49. Waught, J. J., K. Pelley, L. G. Costa, P. Setler & S. J. Enna: A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology 1985, 24, 211-216.
50. Zarrindast, M. R. & E. Moghadampour: Influences of dopamine agonists and antagonists on baclofen antinociception in mice. Arch int. Pharmacodyn. 1991, 309, 42-50.
51. Zarrindast, M. R., A. Nami & D. Farzin: Nicotine potentiates morphine antinociception: a possible cholinergic mechanism. Eur. J. Neuropsychopharmacol. 1996, 7, 127-133.
52. Zarrindast, M. R. & D. Farzin: Nicotine attenuates naloxone-induced jumping in morphine-dependent mice. Eur. J. Pharmacol. 1996, 298, 1-6.